A challenge of IVDR is the ability to keep up with research advancements and allow manufacturers to make improvements to kits easily. The pharmacogenomics sector is constantly changing.

Gene-driven therapies dominate therapeutic strategies, propelled by cutting-edge sequencing platforms and unique biomarker ...

Pharmacogenomics today is a wide-ranging ... in this case neurons and glia, but the biggest challenge is to develop high-throughput means of determining if cells undergo functional changes in ...

Typical approaches from pharmacogenomics combined with systems biology and bioinformatics support these routes (simulations, metagenomics and metabolic network modeling), as well as the patient ...

The scientific terms for these two determinants are pharmacokinetics and pharmacodynamics, and both are critical considerations in the field of pharmacogenomics ... a major challenge for companies ...

In this study, pharmacogenomics and therapeutic drug monitoring were used to evaluate the clinical effectiveness of genotyping chronic pain patients on analgesic therapy. It was hypothesized that ...